Table 4 Spinal MRI features between NMOSD with and without CTD
From: Neuromyelitis optica spectrum disorders with and without connective tissue disorders
NMOSD (39) | NMOSD with CTD (18) | P | |
|---|---|---|---|
Sagittal location | |||
length of lesions (VB) | 4.44 ± 2.89 | 7.56 ± 4.79 | 0.018* |
Short TM at onset, n (%) | 7 (17.9%) | 1 (5.6%) | 0.400 |
Initial short TM, n (%) | 18 (46.2%) | 2 (11.1%) | 0.010* |
Location of spinal lesions, n (%) | |||
Cervical cord | 13 (33.3%) | 2 (11.1%) | 0.148 |
Cervico-thoracic cord | 16 (41.0%) | 10 (55.6%) | 0.306 |
Thoracic cord | 10 (25.6%) | 6 (33.3%) | 0.548 |
Axial location, n (%) | |||
Centrally located | 38 (97.4%) | 18 (100.0%) | 1.000 |
Peripherally located | 1 (2.6%) | 0 (0.0%) | 1.000 |
enhancement | 11 (28.2%) | 8 (44.4%) | 0.227 |
Acute phase | |||
T1 dark, n (%) | 17 (43.6%) | 16 (88.9%) | 0.001* |
T2 BSLs, n (%) | 14 (35.9%) | 13 (72.2%) | 0.011* |
Chronic phase | |||
Fragmentation, n (%) or ‘bead-like’ lesions | 25 (64.1%) | 8 (44.4%) | 0.162 |
Disappearance, n (%) | 9 (23.1%) | 7 (38.9%) | 0.217 |
Atrophy, n (%) | 5 (12.8%) | 3 (16.7%) | 1.000 |